Skip to main content
Premium Trial:

Request an Annual Quote

The Great Debate

Jason Bobe links to a video posted by Tech Review in which Helicos Biosciences' Stanley Lapidus explains why he is involved in George Church's Personal Genome Project and why he's not too worried about his genome becoming public. "I joined it not so much because I am intensely curious about my genome. I am about 60 years old and with maybe one-third or one-quarter left of my life to live. There, I hope, will be few genomic surprises at this late date," Lapidus says. Instead, he later adds that what he expects to get out of this is "an opportunity to participate in what I think is going to be the great public debate on health and privacy in the coming decades."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.